Amdocs (NASDAQ:DOX) Stock: Insider Shimie Hortig Sells 7,264 Shares

Key Points

  • Insider Shimie Hortig sold 8,997 Amdocs shares across transactions on November 10 and 11, for about $381,000 in total. After the November 10 sale, he directly held 174,432 shares.
  • Amdocs reported quarterly EPS of $1.98, matching analysts’ estimates, while revenue of $1.19 billion was up 3.8% year over year. The company announced a quarterly dividend of $0.569 per share, equivalent to a 5.1% yield at the reported share price.
  • Analyst views were mixed, but the consensus rating was Hold, with an average price target of $69.00. Shares traded at $44.79 in the article.

Amdocs Limited (NASDAQ:DOX - Get Free Report) insider Shimie Hortig sold 7,264 shares of the business's stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $42.18, for a total transaction of $306,395.52. Following the sale, the insider directly owned 174,432 shares of the company's stock, valued at $7,357,541.76. This represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Shimie Hortig also recently made the following trade(s):

  • On Wednesday, November 11th, Shimie Hortig sold 1,733 shares of Amdocs stock. The stock was sold at an average price of $43.14, for a total value of $74,761.62.

Amdocs Trading Up 1.5%

Shares of DOX traded up $0.68 during trading hours on Friday, hitting $44.79. The stock had a trading volume of 2,245,070 shares, compared to its average volume of 2,150,916. Amdocs Limited has a 12-month low of $39.96 and a 12-month high of $84.95. The firm has a market cap of $4.84 billion, a P/E ratio of 9.59, a P/E/G ratio of 1.44 and a beta of 0.42. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.94 and a current ratio of 0.94. The company's fifty day simple moving average is $57.51 and its 200 day simple moving average is $60.98.




Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.98. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The firm's quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.83 earnings per share. Equities research analysts forecast that Amdocs Limited will post 5.82 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be paid a $0.5690 dividend. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. The ex-dividend date of this dividend is Thursday, December 31st. Amdocs's payout ratio is currently 48.82%.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Zacks Research downgraded shares of Amdocs from a "hold" rating to a "strong sell" rating in a research report on Monday, November 9th. Weiss Ratings raised shares of Amdocs from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Friday, October 23rd. Stifel Nicolaus cut their target price on shares of Amdocs from $71.00 to $46.00 and set a "buy" rating on the stock in a research note on Wednesday, November 4th. Wall Street Zen lowered shares of Amdocs from a "buy" rating to a "hold" rating in a report on Saturday, November 7th. Finally, Oppenheimer lowered shares of Amdocs from an "outperform" rating to a "market perform" rating in a report on Wednesday, November 4th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, Amdocs currently has a consensus rating of "Hold" and an average price target of $69.00.

View Our Latest Report on DOX

Institutional Investors Weigh In On Amdocs

A number of large investors have recently modified their holdings of the stock. Pzena Investment Management LLC lifted its position in Amdocs by 3.4% during the 3rd quarter. Pzena Investment Management LLC now owns 14,454,911 shares of the technology company's stock worth $826,532,000 after acquiring an additional 469,581 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Amdocs by 19.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,463,797 shares of the technology company's stock worth $226,045,000 after acquiring an additional 571,036 shares during the period. First Trust Advisors LP grew its position in Amdocs by 18.7% in the third quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company's stock valued at $93,652,000 after acquiring an additional 258,098 shares in the last quarter. Bank of America Corp DE grew its position in Amdocs by 29.1% in the first quarter. Bank of America Corp DE now owns 1,262,263 shares of the technology company's stock valued at $82,375,000 after acquiring an additional 284,435 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its stake in shares of Amdocs by 11.2% during the third quarter. Russell Investments Group Ltd. now owns 1,112,976 shares of the technology company's stock valued at $63,703,000 after purchasing an additional 111,800 shares during the period. Institutional investors and hedge funds own 92.02% of the company's stock.

Top Amdocs Stories

Here are a few of the latest stories about DOX:

  • Positive Sentiment: Amdocs is seeking shareholder approval for a 3% quarterly dividend increase, which could bolster its appeal to income-focused investors. Dividend proposal
  • Neutral Sentiment: Call-option trading was unusually active, with 2,152 calls purchased—about 430% above the average daily volume. The activity may reflect bullish positioning, but options trading alone does not establish a lasting change in sentiment.
  • Negative Sentiment: Insider Shimie Hortig sold 8,997 shares across transactions on November 10 and 11, reducing his holdings. The sales may weigh on sentiment, though he retained a substantial position. SEC filing

About Amdocs

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Read More

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Amdocs?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Amdocs and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles